tiprankstipranks
Inhibrx Biosciences Inc (INBX)
NASDAQ:INBX
US Market

Inhibrx Biosciences Inc (INBX) Financial Statements

Compare
18 Followers

Inhibrx Biosciences Inc Financial Overview

Inhibrx Biosciences Inc's market cap is currently $207.29M. The company's EPS TTM is $116.578; its P/E ratio is 0.12; Inhibrx Biosciences Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 200.00K$ 1.80M$ 2.18M$ 7.13M$ 12.81M
Gross Profit$ 200.00K$ 609.00K$ -668.00K$ 4.44M$ -60.69M
Operating Income$ -331.45M$ -219.22M$ -129.12M$ -76.56M$ -67.44M
EBITDA$ -331.45M$ -206.69M$ -125.82M$ -76.56M$ -67.44M
Net Income$ 1.69B$ -241.36M$ -145.23M$ -81.77M$ -75.64M
Balance Sheet
Cash & Short-Term Investments$ 152.60M$ 277.92M$ 273.87M$ 131.30M$ 128.66M
Total Assets$ 180.77M$ 307.89M$ 290.88M$ 150.45M$ 143.74M
Total Debt$ 8.05M$ 210.14M$ 202.07M$ 70.47M$ 37.45M
Net Debt$ -144.55M$ -67.78M$ -71.80M$ -60.83M$ -91.21M
Total Liabilities$ 47.18M$ 264.39M$ 232.82M$ 98.07M$ 68.27M
Stockholders' Equity$ 133.58M$ 43.50M$ 58.06M$ 52.38M$ 75.47M
Cash Flow
Free Cash Flow$ -197.01M$ -197.90M$ -115.99M$ -81.19M$ -49.33M
Operating Cash Flow$ -194.41M$ -193.31M$ -115.30M$ -80.32M$ -47.97M
Investing Cash Flow$ -2.60M$ -4.59M$ -686.00K$ -809.00K$ -1.36M
Financing Cash Flow$ 71.68M$ 201.96M$ 258.55M$ 83.77M$ 166.46M
Currency in USD

Inhibrx Biosciences Inc Earnings and Revenue History

Inhibrx Biosciences Inc Debt to Assets

Inhibrx Biosciences Inc Cash Flow

Inhibrx Biosciences Inc Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis